Related Experiment Video
Updated: Jul 13, 2026

Guided Endodontics: Three-Dimensional Planning and Template-Aided Preparation of Endodontic Access Cavities
Published on: May 24, 2022
Planning for closeout--from Day One
Rodger Shepherd1, Judith L Macer, Deborah Grady
1University of California, San Francisco Veterans Affairs Medical Center 94115, United States.
Abstract:
Clinical trials are often stopped prematurely by Data and Safety Monitoring Boards, sponsors, or the investigators for reasons such as unexpected harmful effects of the intervention, clear lack of benefit, or futility due to sluggish recruitment or an unexpectedly low outcome rate in the placebo group. Planning for closeout, however, usually does not begin until after the trial is well underway. This article describes the experience of the Heart and Estrogen/progestin Replacement Study (HERS) investigators when data from the first year of follow-up revealed a clear but non-significant divergence in outcome rates between the treatment groups, and planning for early closure was initiated. Three advantages of beginning early to plan for closeout are described and approaches to planning closeout are suggested.
Insights
Early planning for clinical trial closeout is crucial. The Heart and Estrogen/progestin Replacement Study (HERS) initiated closeout planning after one year, demonstrating advantages for managing trial cessation.
Area of Science:
- Cardiovascular Research
- Clinical Trial Management
- Pharmacological Studies
Background:
- Clinical trials frequently face premature termination due to safety concerns, lack of efficacy, or futility.
- Proactive planning for trial closeout is often delayed until trials are significantly advanced.
Purpose of the Study:
- To describe the experience of initiating early closeout planning during the Heart and Estrogen/progestin Replacement Study (HERS).
- To highlight the advantages of early closeout planning in clinical trials.
- To suggest approaches for planning trial closeout.
Main Methods:
- The HERS trial investigators initiated closeout planning based on early follow-up data showing outcome rate divergence.
- The article reflects on the HERS experience and proposes strategies for early closeout planning.
Main Results:
- Early data in HERS indicated a non-significant divergence in outcome rates between treatment groups, prompting early closure considerations.
- Initiating closeout planning early offers distinct advantages for managing trial cessation.
Conclusions:
- Early planning for clinical trial closeout, as demonstrated by HERS, is beneficial.
- Proactive strategies for closeout planning should be integrated into trial design and management.
- Effective closeout planning can mitigate challenges associated with premature trial termination.
Related Concept Videos
Planning Nursing Care I
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Planning Nursing Care II
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation
Design Example: Maintaining Level of an Embankment
Open and closed-loop control systems
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal and...
